HDL Atheroprotection by aerobic exercise training in type 2 diabetes mellitus

Medicine and Science in Sports and Exercise

Volumn 40, Issue 5, 2008, Pages 779-786

  Ribeiro, Isabel C D ^a   Iborra, Rodrigo T ^a   Neves, Mônica Q T S ^a   Lottenberg, Simão A ^a   Charf, Ana M ^a   Nunes, Valéria S ^a   Negrão, Carlos E ^a   Nakandakare, Edna R ^a   Quintão, Eder C R ^a   Passarelli, Marisa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Lipoprotein oxidation; Postprandial lipoprotein profile; Prebeta 1 HDL; Reverse cholesterol transport

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

AEROBIC EXERCISE; ARTICLE; ATHEROSCLEROSIS; BODY FAT; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HEART PROTECTION; HUMAN; IN VITRO STUDY; INSULIN RESISTANCE; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; POSTPRANDIAL STATE; SITTING; WAIST CIRCUMFERENCE; ANALYSIS OF VARIANCE; ANTHROPOMETRY; BLOOD; CASE CONTROL STUDY; EXERCISE; MIDDLE AGED;

ANALYSIS OF VARIANCE; ANTHROPOMETRY; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; EXERCISE; FASTING; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 52149115855     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e3181632d2d     Document Type: Article

References (44)

1. Asztalos BF, Collins D, Cupples LA, et al. Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vase Biol. 2005;25:2185-91.
2. Asztalos BF, Demissie S, Cupples LA, et al. LpA-I, LpA-I:A-II HDL and CHD-risk: the Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial. Atherosclerosis. 2006; 188:59-67.
3. Bernard RJ, Jung T, Inkeles SB. Diet and exercise in the treatment of NIDDM. Diabetes Care. 1994;17:1469-72.
4. Bonnefont-Rousselot D, Raji B, Walrand S, et al. An intracellular modulation of free radical production could contribute to the benefical effects of metformin towards oxidative stress. Metabolism. 2003;52:586-9.
5. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57-63.
6. Borggreve SE, De Vries R, Dullaart RP. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, Iecithin: cholesterol acyltransferase and lipid transfer proteins. Eur J Clin Invest. 2003;33(12):1051-69.
7. Brites F, Verona J, De Geitere C, Fruchart JC, Castro G, Wikinski R. Enhanced cholesterol efflux promotion in well-trained soccer players. Metabolism. 2004;53:1262-7.
8. Brites F, Zago V, Verona J, Muzzio ML, Wikinski R, Schreier L. HDL capacity to inhibit LDL oxidation in well-trained triathletes. Life Sciences. 2006;78:3074-81.
9. Cauza E, Hanusch-Enserer U, Strasser B, et al. The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus. Arch Phys Med Rehabil. 2005;86(8):1527-33.
10. Chetiveaus M, Lalanne F, Lambert G, Zair Y, Ouguerram K, Krempf M. Kinetics of prebeta 1 HDL and alphaHDL in type II diabetic patients. Eur J Clin Invest. 2006;36:29-34.
11. Crouse SF, O'Brien BC, Grandjean PW, et al. Training intensity, blood lipids, and apolipoproteins in men with high cholesterol. J Appl Physiol. 1997;82:270-7.
12. Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25:2165-7I.
13. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 1989;6:67-75.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation. Clin Chem. 1972;18(6):499-502.
15. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of paraoxonase/arylesterase: evidence for one esterase catalysing both activities. Drug Dispos. 1991;19:100-6.
16. Ghanbari-Niaki A, Khabazian BM, Hossaini-Kakhak SA, Rahbar-izadeh F, Hedayati M. Treadmill exercise enhances ABCA1 expression in rat liver. Biochem Biophys Res Commun. 2007;361: 841-6.
17. Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res. 2005;36:232-40.
18. Goodyear LJ, Kahn BB. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med. 1998;49:235-61.
19. Gupta AK, Ross EA, Myers JN, Kashyap ML. Increased reverse cholesterol transport in athletes. Metab Clin Exp. 1993;42:684-90.
20. Halle M, Berg A, Garwers U, et al. Influence of 4 weeks' intervention by exercise and diet on low-density lipoprotein subfrac-tions in obese men with type 2 diabetes. Metabolism. 1999;48: 641-4
21. Hirayama S, Miida T, Miyazaki O, Aizawa Y. Preβ 1-HDL concentration is a predictor of carotid atherosclerosis in type 2 diabetic patients. Diabetes Care. 2007;30:1289-91.
22. Kolifa M, Petridou A, Mougios V. Effect of prior exercise on lipemia after a meal of moderate fat content. Eur J Clin Nutr. 2004;58:1327-35.
23. Kraus WE, Houmard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002;347:1483-92.
24. Lakka TA, Laaksonen DE, Lakka HM, et al. Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc. 2003;35(8):1279-86.
25. Lee S, Kuk JL, Katzmarzyk PT, Blair SN, Church TS, Ross R. Cardiorespiratory fitness attenuates metabolic risk independent of abdominal subcutaneous and visceral fat in men. Diabetes Care. 2005;28:895-901.
26. Lehmann R, Engler H, Honegger R, Riesen W, Spinas GA. Alterations of lipolytic enzymes and high-density lipoprotein subfractions induced by physical activity in type 2 diabetes mellitus. Eur J Clin Invest. 2001;31:37-44.
27. Lottenberg SA, Lottenberg AM, Nunes VS, McPherson R, Quintão EC. Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in type II diabetics and normal controls. Atherosclerosis. 1996;127:81-90.
28. Meilhac O, Ramachandran S, Chiang K, Santanam N, Parthasarathy S. Role of arterial wall antioxidant defense in beneficial effects of exercise on atherosclerosis in mice. Artcriocler Thromb Vase Biol. 2001;21:1681-8.
29. Nobecourt E, Jacqueminet S, Hansel B, et al. Defective antioxi-dative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia. Diabetologia. 2005;48:529-38.
30. Ohashi R, Mu H, Wang X, Yao Q, Chen C. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM. 2005;98: 845-56.
31. Olchawa B, Kingwell BA, Hoang A, et al. Physical fitness and reverse cholesterol transport. Arterioscler Thromb Vase Biol. 2004; 24:1087-91.
32. Passarelli M, Shimabukuro AF, Catanozi S, et al. Diminished rate of mouse peritoneal macrophage cholesterol efflux is not related to the degree of HDL glycation in diabetes mellitus. Clin Chim Acta. 2000;301:119-34.
33. Passarelli M, Tang C, McDonald TO, et al. Advanced glycation end product precursors impair ABCAl-dependent cholesterol removal from cells. Diabetes. 2005;54:2198-205.
34. Poirier P, Catellier C, Tremblay A, Nadeau A. Role of body fat loss in the exercise-induced improvement of the plasma lipid profile in non-insulin-dependent diabetes mellitus. Metabolism. 1996;45:1383-7.
35. Ramachandran S, Penumetcha M, Merchant NK, Santanam N, Rong R, Parthasarathy S. Exercise reduces preexisting atherosclerotic lesions in LDL receptor knock out mice. Atherosclerosis. 2005;178:33-8.
36. Ratner R, Goldberg R, Haffner S, et al. Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care. 2005;28:888-94.
37. Stone NJ, Bilek S, Rosenbaum S. Recent National Cholesterol Education Program Treatment Panel II update: adjustments and options. Am J Cardiol. 2005;96:53e-9e.
38. Sviridov D, Kingwell B, Hoang A, Dart A, Nestel P. Single session exercise stimulates formation of pre beta 1-HDL in leg muscle. J Lipid Res. 2003;44:522-6.
39. Tomas M, Elosua R, Senti M, et al. Paraoxonasel-192 polymorphism modulates the effects of regular and acute exercise on paraoxonasel activity. J Lipid Res. 2002;43:713-20.
40. Wei C, Penumetcha M, Santanam N, Liu YG, Garelnabi M, Parthasarathy S. Exercise might favor reverse cholesterol transport and lipoprotein clearance: potential mechanism for its anti-atherosclerotic effects. Biochim Biophys Acta. 2005;1723:124-7.
41. Wei M, Kampert JB, Barlow CE, et al. Relation between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA. 1999;282:1547-53.
42. Williams PT, Albers JJ, Krauss RM, Wood PD. Associations of lecithin: cholesterol acyltransferase (LCAT) mass concentrations with exercise, weight loss, and plasma lipoprotein subfraction concentration in men. Atherosclerosis. 1990;82:53-8.
43. Wong SL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R. Cardiorespiratory fitness is associated with lower abdominal fat independent of body mass index. Med Sci Sports Exerc. 2004;36(2):286-91.
44. Zmuda JM, Yurgalevitch SM, Flynn MM, et al. Exercise training has little effect on HDL levels and metabolism in men with initially low HDL cholesterol. Atherosclerosis. 1998;137:215-21.